Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
16 Nov 2026Polymedics Innovations Inc.AustriaInfluence of SUPRA SDRM on the Healing of Chronic WoundsNot applicableCompleted12 Nov 2026Croma-Pharma GmbHAustriaRevitalis - Midface (Cheek Area)Not applicableRecruiting12 Nov 2026YGION Biomedical GmbHAustriaFirst Study Evaluating the Safety and Dosage of YG-01 in Patients With GlioblastomaPhase 1Not Yet Recruiting9 Nov 2026Aqua Therapeutics, Inc.Austria, ItalyClinical Study on the Safety and the Performance of an Endometrial Ablation System in Women With Abnormal Uterine Bleeding (AUB) and Previous Cesarean DeliveryNot applicableRecruiting4 Nov 2026Boehringer IngelheimUnited States, Argentina, AustriaA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Phase 3Not Yet Recruiting28 Oct 2026MED-EL Elektromedizinische Geräte GmbHAustria, Belgium, GermanyMi2000 TICI Follow-upRecruiting28 Oct 2026Nuvascular IncAustria, BulgariaThe NUVASCULAR HARBOR Occlusion Device EU StudyNot applicableNot Yet Recruiting28 Oct 2026Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.AustriaPhase 1 Study to Evaluate RG002C0106 Injection in Healthy ParticipantsPhase 1Not Yet Recruiting27 Oct 2026AbbVieAustriaReal-World Study of Mirvetuximab Soravtansine in Adult Participants With Platinum-Resistant FRα-Positive Ovarian, Fallopian Tube, and Peritoneal CancerRecruiting27 Oct 2026MED-EL Elektromedizinische Geräte GmbHAustria, Belgium, GermanyMi2000 TICI - Post-market Implantation StudyNot applicableRecruiting22 Oct 2026Terumo Europe N.V.Austria, Belgium, GermanyEvaluation of Safety, Performance and Usability of the TR Band DISTAL Device for Hemostasis Following Distal Radial Access in Coronary ProceduresNot Yet Recruiting// How AOS uses this